128 results
Sepsis Treatment Overview #Management #EM #IM #PCC #Sepsis #Overview #BMJ
Sepsis Treatment ... Overview #Management ... #EM #IM #PCC #Sepsis
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Indications #Pathophys #Management ... #EM #IM #PCC #Catecholamine
Antinuclear Antibody Testing - Nuclear and Cytoplasmic Patterns
Nuclear Patterns:
 • Homogeneous pattern: 
   -
pattern: - PBC ... , SSc, PBC/SSc OS ... , PBC/SjS OS ... , RA, PBC, UCTD ... differential #diagnosis #rheumatology
Autoantibodies and their Disease Associations
ANA - Non-specific; common in SLE, autoimmune hepatitis
Anti-CCP, Rheumatoid factor - RA
Anti-dsDNA
Non-specific; common in SLE ... RA Anti-dsDNA - SLE ... - Drug-induced SLE ... biliary cirrhosis (PBC ... diagnosis #table #rheumatology
Indications for ERCP
1. Biliary Tract Diseases:
 • Biliary obstruction: Choledocholithiasis, Malignant biliary strictures, Benign biliary strictures
biliary strictures (PSC ... pancreatitis (treatment ... fluid collections (PFC ... pancreatoscopy, Drainage of PFC ... #Indications #management
Premature Ventricular Complexes (PVC's) - Summary Framework

Why PVCs?  Can be the first manifestation of cardiac
Presyncope PVC ... Diagnosis: • PAC ... A PAC also has a ... more intensive treatment ... Complexes #PVCs #PVC
Consensus diagnostic criteria for asthma-COPD overlap syndrome (ACOS) in patients with airflow limitation. COPD=chronic obstructive pulmonary
obstructive pulmonary disease ... normal #Diagnosis #PCC ... #IM #ACOS #AsthmaCOPD
The 6 C’s of Primary Sclerosing Cholangitis (PSC)
PSC is a chronic, cholestatic, immune-mediated disease characterized by
) PSC is a chronic ... • COVERT - PSC ... patients with PSC ... management. ... Cholangitis #diagnosis #management
A good approach when dealing with hypotension at the bedside includes using the following systematic four
Resistance #Diagnosis #Management ... #EM #IM #PCC #Hypotensive
Systemic Lupus Erythematosus - Summary
Antinuclear (ANA) - 95% - Initial screening test
Anti-dsDNA - 50%
 • Associated
• Specific for SLE ... Treatment: • ... Erythematosus #SLE ... Summary #diagnosis #rheumatology ... #management